Cepheid disclosed on 8 Jun 2010 that the US Food and Drug Administration has approved its Xpert SA Nasal Complete test. The molecular diagnostic product can identify and differentiate Staphylococcus aureas and Methicillin-resistant Staphylococccus aureus (MRSA) colonization and provide results in less than 1 hr. Cepheid will start offering the test in Jul 2010. Xpert SA Nasal Complete runs on Cepheid’s GeneXpert system.
Lee Ann Torrans
ltorrans@gmail.com




Comments
No one has said anything yet.